PEOPLE - Changes at Medrad, Schering AG's US subsidiary:
This article was originally published in Clinica
Executive Summary
Thomas Witmer is to retire in June as president and CEO of Medrad, Schering AG's US subsidiary which develops imaging-related equipment and disposable products. He will be succeeded by vice-president and general manager John Friel. The $120 million company also announced the following organisational changes: Michael Howard becomes senior vice-president of finance, administration and business development and CFO, Clifford Kress has been promoted to vice-president of marketing and business manager, and Joseph Havrilla becomes senior vice-president of new product design.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.